Organization · Private Equity
Keensight Capital
Keensight Capital is a European Growth Buyout investor specializing in the Technology and Healthcare sectors. The firm partners with management teams of fast-growing companies, providing capital and strategic guidance.
Overview
What Keensight Capital does
What Keensight Capital is
Keensight Capital is a European Growth Buyout investor specializing in the Technology and Healthcare sectors. The firm partners with management teams of fast-growing companies, providing capital and strategic guidance.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- March 4, 2026
Official channels
Find Keensight Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Keensight Capital as a funder
Investment thesis
Keensight Capital invests in fast-growing and profitable companies with revenues ranging from €10 million to €400 million. The firm emphasizes responsible investing and integrates ESG principles into its investment decisions.
Focus narrative
Keensight Capital invests in fast-growing and profitable companies with revenues between €10 million and €400 million. The firm provides investment tickets ranging from €10 million to €800 million, acting as either minority or majority partners. Their strategy includes financing organic growth, enabling strategic acquisitions, and providing liquidity to existing shareholders, all while emphasizing responsible investing.
Terms and economics
- Typical check
- $10,000,000–$800,000,000
Focus and fit
- Sectors
- Healthcare
- Regions
- Europe · Global
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Notable portfolio companies include Bedfont Scientific, a leader in non-invasive breath analysis medical devices; Decision Focus, a global software developer of Governance, Risk, and Compliance solutions; Isto Biologics, a leading orthobiologics and regenerative MedTech company; Uve, a data management and analytics software provider for the Consumer-Packaged Goods industry; Dimo Maint, a leading European maintenance and facility management software vendor; Actico, a provider of regulatory compliance and risk management SaaS solutions; MetaCompliance, a leading European HRM software vendor; and Sogelink, a provider of digitalization solutions for civil engineering.
Common questions
What to know about Keensight Capital
Upseed classifies Keensight Capital under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.